Concerted effort by governments, regulators, and industry is rapidly expanding development of new therapies for the more than 7,000 known rare diseases.
https://www.pharmalive.com/wp-content/uploads/2016/09/Lisa-Pitt-03.jpg100100Administratorhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngAdministrator2016-06-08 20:40:192017-06-15 14:32:30Incentives, Opportunities Abound as Orphan Drug Demand Grows